Artigo Revisado por pares

Feasibility of Pulmonary Vein Ostia Radiofrequency Ablation in Patients with Atrial Fibrillation: A Multicenter Study (CACAF Pilot Study)

2003; Wiley; Volume: 26; Issue: 1p2 Linguagem: Inglês

10.1046/j.1460-9592.2003.00033.x

ISSN

1540-8159

Autores

Giuseppe Stabile, Emanuele Bertaglia, Gaetano Senatore, Antonio De Simone, Francesca Zerbo, Giovanni Carreras, Pietro Turco, Pietro Pascotto, M. Fazzari,

Tópico(s)

Venous Thromboembolism Diagnosis and Management

Resumo

STABILE, G., et al.: Feasibility of Pulmonary Vein Ostia Radiofrequency Ablation in Patients with Atrial Fibrillation: A Multicenter Study (CACAF Pilot Study) Radiofrequency (RF) catheter ablation has been proposed as a treatment of atrial fibrillation (AF). Several approaches have been reported and success rates have been dependent on procedural volume and operator's experience. This is the first report of a multicenter study of RF ablation of AF. We treated 44 men and 25 women with paroxysmal (n = 40) or persistent (n = 29) , drug refractory AF. Circular pulmonary vein (PV) ostial lesions were deployed transseptally, during sinus rhythm (n = 42) or AF ( n = 26) , under three‐dimensional electroanatomic guidance. Cavo‐tricuspid isthmus ablation was performed in 27 (40%) patients. The mean procedure time was 215 ± 76 minutes (93–530), mean fluoroscopic exposure 32 ± 14 minutes (12–79), and mean number of RF pulses per patient 56 ± 29 (18–166). The mean numbers of separate PV ostia mapped and isolated per patient were 3.9 ± 0.5 , and 3.8 ± 0.7 , respectively. Major complications were observed in 3 (4%) patients, including pericardial effusion, transient ischemic attack, and tamponade. At 1‐month follow‐up, 21 of 68 (31%) patients had had AF recurrences, of whom 8 required electrical cardioversion. After the first month, over a mean period of 9 ± 3 (5–14) months, 57 (84%) patients remained free of atrial arrhythmias. RF ablation of AF by circumferential PV ostial ablation is feasible with a high short‐term success rate. While the procedure and fluoroscopic exposure duration were short, the incidence of major cardiac complications was not negligible. (PACE 2003; 26[Pt. II]:284–287)

Referência(s)